• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于炎症-免疫-营养评分(IINS)和经典临床指标的列线图模型预测结外自然杀伤/T细胞淋巴瘤的预后

A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma.

作者信息

He Yanxia, Luo Zhumei, Chen Haoqing, Ping Liqing, Huang Cheng, Gao Yan, Huang Huiqiang

机构信息

Department of Oncology, The Third People's Hospital of Chengdu, Sichuan, People's Republic of China.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.

出版信息

J Inflamm Res. 2024 Apr 4;17:2089-2102. doi: 10.2147/JIR.S452521. eCollection 2024.

DOI:10.2147/JIR.S452521
PMID:38595337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11001545/
Abstract

BACKGROUND

Systemic inflammation, immunity, and nutritional status are closely related to patients' outcomes in several kinds of cancers. This study aimed to establish a new nomogram based on inflammation-immunity-nutrition score (IINS) to predict the prognosis of extranodal natural killer/T-cell lymphoma (ENKTL) patients.

METHODS

The clinical data of 435 patients with ENTKL were retrospectively reviewed and randomly assigned to training cohort (n=305) and validation cohort (n=131) at a ratio of 7:3. Cox regression analysis was employed to identify independent prognostic factors and develop a nomogram in the training cohort. Harrell's concordance index (C-index), calibration curve, receiver operating characteristic (ROC) curve, and decision curve analysis (DCA) curve were employed to assess the performance of the nomogram and compare it with traditional prognostic systems (PINK, IPI, KPI). Internal validation was performed using 1000 bootstrap resamples in the validation cohort. Kaplan-Meier survival analyses were conducted to compare the overall survival (OS) of patients in different risk groups.

RESULTS

In the training cohort, in addition to several classic parameters, IINS was identified as an independent prognostic factor significantly associated with the OS of patients. The nomogram established based on the independent prognostic indicators showed superior survival prediction efficacy, with C-index of 0.733 in the training cohort and 0.759 in the validation cohort compared to the PINK (0.636 and 0.737), IPI (0.81 and 0.707), and KPI (0.693 and 0.639) systems. Furthermore, compared with PINK, IPI, and IPI systems, the nomogram showed relatively superior calibration curves and more powerful prognostic discrimination ability in predicting the OS of patients. DCA curves revealed some advantages in terms of clinical applicability of the nomogram compared to the PINK, IPI, and IPI systems.

CONCLUSION

Compared with traditional prognostic systems, the nomogram showed promising prospects for risk stratification in ENKTL patient prognosis, providing new insights into the personalized treatment.

摘要

背景

全身炎症、免疫和营养状况与多种癌症患者的预后密切相关。本研究旨在基于炎症-免疫-营养评分(IINS)建立一种新的列线图,以预测结外自然杀伤/T细胞淋巴瘤(ENKTL)患者的预后。

方法

回顾性分析435例ENTKL患者的临床资料,并按7:3的比例随机分为训练队列(n = 305)和验证队列(n = 131)。采用Cox回归分析确定独立预后因素,并在训练队列中建立列线图。采用Harrell一致性指数(C指数)、校准曲线、受试者工作特征(ROC)曲线和决策曲线分析(DCA)曲线评估列线图的性能,并与传统预后系统(PINK、IPI、KPI)进行比较。在验证队列中使用1000次自抽样重采样进行内部验证。进行Kaplan-Meier生存分析,以比较不同风险组患者的总生存期(OS)。

结果

在训练队列中,除了几个经典参数外,IINS被确定为与患者OS显著相关的独立预后因素。基于独立预后指标建立的列线图显示出优越的生存预测效能,训练队列中的C指数为0.733,验证队列中的C指数为0.759,优于PINK(0.636和0.737)、IPI(0.81和0.707)和KPI(0.693和0.639)系统。此外,与PINK、IPI和IPI系统相比,列线图在预测患者OS方面显示出相对优越的校准曲线和更强的预后判别能力。DCA曲线显示,与PINK、IPI和IPI系统相比,列线图在临床适用性方面具有一些优势。

结论

与传统预后系统相比,列线图在ENKTL患者预后风险分层方面显示出良好的前景,为个性化治疗提供了新的见解。

相似文献

1
A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma.基于炎症-免疫-营养评分(IINS)和经典临床指标的列线图模型预测结外自然杀伤/T细胞淋巴瘤的预后
J Inflamm Res. 2024 Apr 4;17:2089-2102. doi: 10.2147/JIR.S452521. eCollection 2024.
2
The prognostic value of controlling nutritional status (CONUT) score-based nomogram on extranodal natural killer/T cell lymphoma patients.基于控制营养状况(CONUT)评分的列线图对结外自然杀伤/T 细胞淋巴瘤患者的预后价值。
Ann Hematol. 2023 Jun;102(6):1433-1442. doi: 10.1007/s00277-023-05232-3. Epub 2023 Apr 19.
3
Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma.改良全身炎症评分对结外自然杀伤/T细胞淋巴瘤患者的预后价值
Front Pharmacol. 2020 Sep 30;11:593392. doi: 10.3389/fphar.2020.593392. eCollection 2020.
4
[Systemic Inflammatory Markers Can Improve Survival Prediction of Patients with Diffuse Large B-Cell Lymphoma: Model Development and Evaluation].[全身炎症标志物可改善弥漫性大B细胞淋巴瘤患者的生存预测:模型开发与评估]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Aug;32(4):1136-1145. doi: 10.19746/j.cnki.issn.1009-2137.2024.04.025.
5
The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.炎症-免疫-营养评分对肝细胞癌患者术后生存及复发的预后意义
Front Oncol. 2022 Aug 9;12:913731. doi: 10.3389/fonc.2022.913731. eCollection 2022.
6
An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers.基于临床特征和全身炎症标志物的弥漫性大 B 细胞淋巴瘤患者总生存的外部验证列线图。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231180785. doi: 10.1177/15330338231180785.
7
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.在现代化疗时代,列线图修订风险指数的验证及其与其他模型在结外鼻型 NK/T 细胞淋巴瘤中的比较:预后和临床决策的指征。
Leukemia. 2021 Jan;35(1):130-142. doi: 10.1038/s41375-020-0791-3. Epub 2020 Mar 9.
8
[Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].[一种预测根治性肾切除术后总生存期的新型列线图的建立与验证]
Zhonghua Zhong Liu Za Zhi. 2023 Aug 23;45(8):681-689. doi: 10.3760/cma.j.cn112152-20221027-00722.
9
A Nomogram Model for Predicting Recurrence of Stage I-III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors.基于炎症-免疫-营养评分(IINS)和传统经典预测指标的I-III期子宫内膜癌复发预测列线图模型
J Inflamm Res. 2022 May 22;15:3021-3037. doi: 10.2147/JIR.S362166. eCollection 2022.
10
Prognostic value of prognostic nutritional index on extranodal natural killer/T-cell lymphoma patients: A multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group.预后营养指数对结外自然杀伤/T 细胞淋巴瘤患者的预后价值:淮海淋巴瘤工作组 1022 例多中心倾向评分匹配分析。
Hematol Oncol. 2023 Aug;41(3):380-388. doi: 10.1002/hon.3124. Epub 2023 Jan 29.

引用本文的文献

1
Combined fibrinogen concentration and neutrophil-to-lymphocyte ratio, an integrative model of the inflammatory response and coagulation cascades, for predicting prognosis in patients with upper tract urothelial carcinoma.纤维蛋白原浓度与中性粒细胞与淋巴细胞比值联合,一种炎症反应和凝血级联的综合模型,用于预测上尿路尿路上皮癌患者的预后。
Biomol Biomed. 2025 Apr 3;25(5):1126-1137. doi: 10.17305/bb.2024.11039.

本文引用的文献

1
The prognostic value of controlling nutritional status (CONUT) score-based nomogram on extranodal natural killer/T cell lymphoma patients.基于控制营养状况(CONUT)评分的列线图对结外自然杀伤/T 细胞淋巴瘤患者的预后价值。
Ann Hematol. 2023 Jun;102(6):1433-1442. doi: 10.1007/s00277-023-05232-3. Epub 2023 Apr 19.
2
Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management.结外自然杀伤细胞/ T细胞淋巴瘤:病理学与临床管理概述
Semin Hematol. 2022 Oct;59(4):198-209. doi: 10.1053/j.seminhematol.2022.10.002. Epub 2022 Nov 12.
3
Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study.
淋巴细胞与单核细胞比值及全身炎症聚集指数在食管癌患者中的临床应用:一项回顾性队列研究
Cancer Cell Int. 2023 Jan 27;23(1):13. doi: 10.1186/s12935-023-02856-3.
4
Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Extramural Vascular Invasion (EMVI) in Locally Advanced Rectal Cancer.淋巴细胞与单核细胞比值(LMR)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)与局部进展期直肠癌外膜血管侵犯(EMVI)的相关性。
Curr Oncol. 2022 Dec 30;30(1):545-558. doi: 10.3390/curroncol30010043.
5
Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Cancer Patients Undergoing Immune Checkpoint Inhibitors.淋巴细胞与单核细胞比值(LMR)在接受免疫检查点抑制剂治疗的癌症患者中的预后价值。
Dis Markers. 2022 Dec 23;2022:3610038. doi: 10.1155/2022/3610038. eCollection 2022.
6
The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.炎症-免疫-营养评分对肝细胞癌患者术后生存及复发的预后意义
Front Oncol. 2022 Aug 9;12:913731. doi: 10.3389/fonc.2022.913731. eCollection 2022.
7
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.基于抗PD-1抗体的治疗方案在结外NK/T细胞淋巴瘤相关噬血细胞性淋巴组织细胞增生症治疗中的新兴作用。
J Cancer Res Clin Oncol. 2023 May;149(5):2017-2027. doi: 10.1007/s00432-022-04147-2. Epub 2022 Jul 9.
8
A Nomogram Model for Predicting Recurrence of Stage I-III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors.基于炎症-免疫-营养评分(IINS)和传统经典预测指标的I-III期子宫内膜癌复发预测列线图模型
J Inflamm Res. 2022 May 22;15:3021-3037. doi: 10.2147/JIR.S362166. eCollection 2022.
9
Prognostic role of controlling nutritional status score in hematological malignancies.控制营养状况评分在血液恶性肿瘤中的预后作用。
Hematology. 2022 Dec;27(1):653-658. doi: 10.1080/16078454.2022.2078040.
10
Prognostic value of inflammation-immunity-nutrition score in patients with hepatocellular carcinoma treated with anti-PD-1 therapy.炎症-免疫-营养评分在接受抗 PD-1 治疗的肝细胞癌患者中的预后价值。
J Clin Lab Anal. 2022 May;36(5):e24336. doi: 10.1002/jcla.24336. Epub 2022 Mar 21.